CAR‐NK, a Splendid Strategy for Cancer, Especially for Gynecologic Tumor
ABSTRACT Background NK cells are a class of innate lymphocytes capable of nonspecifically killing tumor cells without MHC restriction or prior sensitization. Recent advancements in biotechnology, particularly the development of chimeric antigen receptors (CAR) and related technologies, have enabled...
Saved in:
| Main Authors: | Yisen Cao, Liying Wang, Liang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.70210 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-NK cells: harnessing the power of natural killers for advanced cancer therapy
by: Filipa D. dos Reis, et al.
Published: (2025-05-01) -
Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01) -
Leukoreduction filter derived NK cells offer a promising source for off the shelf CAR NK cell immunotherapy
by: Ali Moazzeni, et al.
Published: (2025-04-01) -
The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors
by: M. R. Khaliulin, et al.
Published: (2024-04-01) -
Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways
by: Bailin He, et al.
Published: (2025-04-01)